Chitosan hybrid nanoparticles as a theranostic platform for targeted doxorubicin/VEGF shRNA co-delivery and dual-modality fluorescence imaging

RSC Advances ◽  
2016 ◽  
Vol 6 (35) ◽  
pp. 29685-29696 ◽  
Author(s):  
Hong Yang ◽  
Min Xu ◽  
Shun Li ◽  
Xue Shen ◽  
Tingting Li ◽  
...  
Keyword(s):  
Cancer Therapy ◽  
Fluorescence Imaging ◽  
Hybrid Nanoparticles ◽  
Dual Modality ◽  
Targeted Drug ◽  
Potential Cancer

Chitosan hybrid nanoparticles were fabricated as a targeted drug/gene co-delivery nanovector for potential cancer therapy and dual-modality fluorescence imaging.

Bioinspired Synthesis of Intrinsically 177Lu-Labeled Hybrid Nanoparticles for Potential Cancer Therapy

2020 ◽  
Vol 59 (52) ◽  
pp. 22492-22500
Author(s):  
Rubel Chakravarty ◽  
Apurav Guleria ◽  
Sachin Jadhav ◽  
Chandan Kumar ◽  
Anil Krishna Debnath ◽  
...  
Keyword(s):  
Cancer Therapy ◽  
Hybrid Nanoparticles ◽  
Bioinspired Synthesis ◽  
Potential Cancer

Multifunctional FePt–Au heterodimers: promising nanotheranostic agents for dual-modality MR/CT imaging diagnosis and in situ cancer therapy

RSC Advances ◽  
2016 ◽  
Vol 6 (109) ◽  
pp. 107331-107336 ◽  
Author(s):  
Jinlong Wang ◽  
Ludan Yue ◽  
Zunfu Hu ◽  
Zhichao Dai ◽  
Yafei Qi ◽  
...  
Keyword(s):  
Cancer Therapy ◽  
Potential Application ◽  
Ct Imaging ◽  
Hybrid Nanoparticles ◽  
Imaging Diagnosis ◽  
Dual Modality ◽  
Hydrothermal Approach

We report the synthesis of multifunctional FePt–Au hybrid nanoparticles via a simple hydrothermal approach and their potential application in cancer dual-modality MR/CT imaging diagnosis and simultaneous in situ therapy.

Lipid-based Nanoplatforms in Cancer Therapy: Recent Advances and Applications

2020 ◽  
Vol 20 (4) ◽  
pp. 271-287 ◽  
Author(s):  
Kuldeep Rajpoot
Keyword(s):  
Drug Delivery ◽  
Cancer Therapy ◽  
Adverse Effects ◽  
Targeted Drug Delivery ◽  
Tumor Therapy ◽  
Cancer Therapies ◽  
Medication Delivery ◽  
Lipid Nanocarriers ◽  
Targeted Drug ◽  
Drug Nanocarriers

Though modern available cancer therapies are effective, they possess major adverse effects, causing non-compliance to patients. Furthermore, the majority of the polymeric-based medication platforms are certainly not universally acceptable, due to their several restrictions. With this juxtaposition, lipid-based medication delivery systems have appeared as promising drug nanocarriers to replace the majority of the polymer-based products because they are in a position to reverse polymer as well as, drug-associated restrictions. Furthermore, the amalgamation of the basic principle of nanotechnology in designing lipid nanocarriers, which are the latest form of lipid carriers, has tremendous chemotherapeutic possibilities as tumor-targeted drug-delivery pertaining to tumor therapy. Apart from this, it is reported that nearly 40% of the modern medication entities are lipophilic. Moreover, research continues to be efficient in attaining a significant understanding of the absorption and bioavailability of the developed lipids systems.

Protein Nanocarriers for Targeted Drug Delivery for Cancer Therapy

2019 ◽  
pp. 173-204 ◽  
Author(s):  
Mahadevappa Y. Kariduraganavar ◽  
Geetha B. Heggannavar ◽  
Sandra Amado ◽  
Geoffrey R. Mitchell
Keyword(s):  
Drug Delivery ◽  
Cancer Therapy ◽  
Targeted Drug Delivery ◽  
Targeted Drug

Exploring potential of quantum dots as dual modality for cancer therapy and diagnosis

2019 ◽  
Vol 49 ◽  
pp. 352-364 ◽  
Author(s):  
Nishant S. Kulkarni ◽  
Yadir Guererro ◽  
Nilesh Gupta ◽  
Aaron Muth ◽  
Vivek Gupta
Keyword(s):  
Quantum Dots ◽  
Cancer Therapy ◽  
Dual Modality ◽  
Therapy And Diagnosis

Targeted drug delivery for cancer therapy

2013 ◽  
pp. 31-56 ◽  
Author(s):  
D.L. Stirland ◽  
J.W. Nichols ◽  
T.A. Denison ◽  
Y.H. Bae
Keyword(s):  
Drug Delivery ◽  
Cancer Therapy ◽  
Targeted Drug Delivery ◽  
Targeted Drug
Sign in / Sign up

Export Citation Format

Share Document